LAURA BUTCH: Open Payments
NPI 1952974206 · APPLETON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 26 payments from 13 companies in 2025. Trend: 2023 $913 · 2024 $787 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $234 |
| Alnylam Pharmaceuticals Inc. | 3 | $81 |
| GENZYME CORPORATION | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Abbott Laboratories | 2 | $29 |
| PFIZER INC. | 1 | $23 |
| Edwards Lifesciences Corporation | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $21 |
Products named: LEQVIO, ONPATTRO, FABRAZYME, ELIQUIS, FARXIGA, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, VYNDAQEL, SAPIEN 3 Ultra RESILIA.
Industry payments across WI — which companies pay providers there.
